CorMedix (NASDAQ: CRMD)
CorMedix Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
CorMedix Company Info
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.
News & Analysis
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Why Shares of CorMedix Are Slumping Thursday
The company announced a stock sale and the sale of prefunded warrants.
Why CorMedix Stock Was Plummeting on Tuesday
Bad news on the regulatory front leads investors to bail en masse from the company.
Why CorMedix Stock Is Getting Crushed Today
The company announced a delay with resubmitting for FDA approval of its DefenCath antibacterial and antifungal solution.
Why CorMedix Stock Is Crashing Today
The FDA gave a thumbs-down to CorMedix's antibacterial/anti-fungal catheter lock.
Here's Why CorMedix Dropped as Much as 27.1% Today
The company announced an update after meeting the FDA.
Valuation
Earnings Transcripts
CorMedix (CRMD) Q4 2024 Earnings Call Transcript
CRMD earnings call for the period ending December 31, 2024.
CorMedix (CRMD) Q3 2024 Earnings Call Transcript
CRMD earnings call for the period ending September 30, 2024.
CorMedix (CRMD) Q2 2024 Earnings Call Transcript
CRMD earnings call for the period ending June 30, 2024.
CorMedix (CRMD) Q1 2024 Earnings Call Transcript
CRMD earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.